Yu-Chang Liu

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Endoplasmic Reticulum Stress

Metastatic Colorectal Cancer

Top Venues

Journal of clinical medicine

Journal of cellular and molecular medicine

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Yu-Chang Liu, Cheng Hsun Lin, Kuan-Tin Chen, De-Wei Lai, Fei-Ting Hsu
Inactivation of EGFR/ERK/NF-κB signalling associates with radiosensitizing effect of 18β-glycyrrhetinic acid on progression of hepatocellular carcinoma. Journal of cellular and molecular medicine (2023)
Fei-Ting Hsu, Yu-Chang Liu, Chang-Liang Tsai, Po-Fu Yueh, Chih-Hsien Chang, Keng-Li Lan
Preclinical Evaluation of Recombinant Human IL15 Protein Fused with Albumin Binding Domain on Anti-PD-L1 Immunotherapy Efficiency and Anti-Tumor Immunity in Colon Cancer and Melanoma. Cancers 13 (8) (2021)
Po-Jung Pan, Yu-Chang Liu, Fei-Ting Hsu
Protein Kinase B and Extracellular Signal-Regulated Kinase Inactivation is Associated with Regorafenib-Induced Inhibition of Osteosarcoma Progression In Vitro and In Vivo. Journal of clinical medicine 8 (6) (2019)
Wei-Ting Chen, Fei-Ting Hsu, Yu-Chang Liu, Cheng-Hsien Chen, Li-Cho Hsu, Song-Shei Lin
Fluoxetine Induces Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits ERK/NF-κB-Modulated Anti-Apoptotic and Invasive Potential in Hepatocellular Carcinoma Cells In Vitro. International journal of molecular sciences 20 (3) (2019)